Performance analysis of Processa Pharmaceuticals (PCSA)
Annual Return
Over the past 3 years, PCSA has had an average annual return of -77.28%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, PCSA has had an average annual return of -76.97%, underperforming the benchmark SPY, which returned +12.73% annual.
Since Oct 10, 2017, PCSA has had an average annual return of -43.35%, underperforming the benchmark SPY, which returned +14.82% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -21.84% | -87.01% | -86.79% | -69.58% | -77.55% | -25.70% | -63.36% | +400% | +649.97% | -27.27% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.60% | -27.47% | +16.67% | +6.49% | -4.88% | -25.64% | +17.24% | -21.84% | |||||
| 2025 | -26.57% | -15.45% | -32.69% | -30.36% | +13.85% | -30.18% | +2.58% | -10.06% | +1.40% | +103.45% | -33.56% | -55.61% | -87.01% |
| 2024 | -64.73% | +4.25% | -3.86% | -7.81% | -32.14% | +51.38% | -6.25% | -34.32% | -0.67% | -15.70% | +0.11% | -23.52% | -86.79% |
| 2023 | -22.27% | -21.65% | -25.35% | +25.97% | -1.58% | -19.76% | -11.55% | -28.63% | -20.32% | +40.28% | +82.34% | -47.72% | -69.58% |
| 2022 | -24.49% | +3.51% | -21.41% | -7.97% | -7.94% | +10.20% | +10.32% | -11.29% | -17.82% | -6.19% | -10.40% | -42.09% | -77.55% |
| 2021 | -4.47% | +81.27% | -4.55% | -24.95% | -24.82% | +33.17% | -26.98% | +9.03% | +31.44% | -19.25% | -21.10% | -10.26% | -25.70% |
| 2020 | -54.17% | +18.18% | +2.56% | -25.00% | +6.67% | +12.50% | -5.56% | -7.65% | +26.12% | -58.48% | +54.50% | +3.86% | -63.36% |
| 2019 | -11.11% | -18.75% | -3.85% | -4.00% | +4.17% | -2.40% | +0% | -0.41% | +7% | -3.85% | -40.00% | +1,100.01% | +400% |
| 2018 | +754.13% | -26.83% | +46% | -9.82% | -11.39% | +34.29% | -36.38% | +0.34% | +45% | -19.54% | +0% | +2.86% | +649.97% |
| 2017 | -12.12% | -8.63% | -9.43% | -27.27% |
Drawdown analysis of Processa Pharmaceuticals (PCSA)
The maximum drawdown for the PCSA was -99.98%, occurring on Feb 23, 2026. This drawdown has not yet recovered.
The current PCSA drawdown is -99.98%.
Since Oct 10, 2017 PCSA has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 3 times
- 30% or more: 4 times
- 20% or more: 5 times
- 10% or more: 6 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.98% | Dec 30, 2019 | 1542 | Feb 23, 2026 | Ongoing | Ongoing | Ongoing |
| -72.00% | Mar 12, 2018 | 425 | Dec 5, 2019 | 12 | Dec 23, 2019 | 437 |
| -42.86% | Jan 10, 2018 | 38 | Mar 7, 2018 | 3 | Mar 12, 2018 | 41 |
| -36.99% | Oct 19, 2017 | 20 | Nov 16, 2017 | 15 | Jan 9, 2018 | 35 |
| -20.00% | Dec 23, 2019 | 2 | Dec 26, 2019 | 2 | Dec 30, 2019 | 4 |
| -15.72% | Oct 13, 2017 | 3 | Oct 18, 2017 | 1 | Oct 19, 2017 | 4 |
| -8.82% | Oct 11, 2017 | 1 | Oct 12, 2017 | 1 | Oct 13, 2017 | 2 |